子宫肌瘤是育龄期妇女最常见的女性生殖系统良性肿瘤,多见于30~50岁妇女,发病率为20%~30%,有报道称其发病率高达50%。目前病因尚未十分明确,治疗方法有手术治疗和药物治疗,仍以手术为主,且逐渐向微创及保留子宫的方向发展。药物治疗是子宫肌瘤治疗中重要组成部分,可作为围绝经期或术前辅助治疗使用,具有良好的近期疗效,根据子宫肌瘤的临床表现及患者自身特征,选择适宜的治疗方法,是非常重要的。 Uterine fibroids are the most common female reproductive system benign tumors of childbearing women, more common in women aged 30 to 50, the incidence of 20% to 30%, there are reports that the incidence of up to 50%. The cause is not yet clear, the treatment of surgical treatment and drug treatment, surgery is still the main, and gradually to the direction of minimally invasive and retained the uterus. Medical treatment is an important part of the treatment of uterine fibroids, can be used as a perimenopausal or preoperative adjuvant therapy, with good short-term efficacy, according to the clinical manifestations of uterine fibroids and patients with their own characteristics, select the appropriate treatment is very important.